Dietary Monosaccharide Supplementation in Patients With Congenital Disorders of Glycosylation

Description

Researchers are trying to assess whether the use of simple sugars given as a daily dietary supplement can improve the health of children with congenital disorders of glycosylation (CDG).

Conditions

Congenital Disorder of Glycosylation

Study Overview

Study Details

Study overview

Researchers are trying to assess whether the use of simple sugars given as a daily dietary supplement can improve the health of children with congenital disorders of glycosylation (CDG).

Dietary Monosaccharide Supplementation in Patients With Congenital Disorders of Glycosylation

Dietary Monosaccharide Supplementation in Patients With Congenital Disorders of Glycosylation

Condition
Congenital Disorder of Glycosylation
Intervention / Treatment

-

Contacts and Locations

Rochester

Mayo Clinic in Rochester, Rochester, Minnesota, United States, 55905

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Patient has a biochemically and genetically proven congenital disorder of glycosylation
  • * Patient is receiving (or planning to receive) oral simple sugar supplementation
  • * Aldolase B deficiency
  • * Galactosemia
  • * Hemolytic uremic syndrome
  • * Severe anemia
  • * Galactose intolerance

Ages Eligible for Study

to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Mayo Clinic,

David Deyle, MD, PRINCIPAL_INVESTIGATOR, Mayo Clinic

Study Record Dates

2024-12